(Q43738717)

26 November 2017

WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment (English)

1 reference

26 November 2017

T P Phan

1

1 reference

26 November 2017

C H Crane

2

1 reference

26 November 2017

N A Janjan

3

1 reference

26 November 2017

E Vrdoljak

4

1 reference

26 November 2017

L Milas

5

1 reference

26 November 2017

K A Mason

6

1 reference

26 November 2017

1 January 2001

1 reference

International Journal of Pancreatology

26 November 2017

1 reference

26 November 2017

29

1 reference

26 November 2017

1

1 reference

26 November 2017

19-23

1 reference

Enhancement of tumor radioresponse in vivo by gemcitabine

26 November 2017

1 reference

12 December 2020

Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients

1 reference

12 December 2020

Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer

1 reference

12 December 2020

Current approaches and future strategies for pancreatic carcinoma

1 reference

12 December 2020

Amifostine and combined-modality therapeutic approaches

1 reference

12 December 2020

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity

1 reference

12 December 2020

Chemo-radiotherapy: radiosensitizing nucleoside analogues (review).

1 reference

12 December 2020

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

12 December 2020

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

12 December 2020

Radioprotective effects of amifostine.

1 reference

12 December 2020

Microcolony Survival Assay for Cells of Mouse Intestinal Mucosa Exposed to Radiation

1 reference

12 December 2020

Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721

1 reference

12 December 2020

Biology-based combined-modality radiotherapy: workshop report.

1 reference

12 December 2020

Gemcitabine: progress in the treatment of pancreatic cancer

1 reference

12 December 2020

Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine)

1 reference

12 December 2020

Adjuvant and neoadjuvant chemoradiation therapy for primary colorectal cancer

1 reference

12 December 2020

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

1 reference

12 December 2020

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

12 December 2020

Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

1 reference

12 December 2020

Chemoprotection in anticancer therapy: the emerging role of amifostine (WR-2721).

1 reference

12 December 2020

Identifiers

DOI

10.1385/IJGC:29:1:19

1 reference

26 November 2017

1 reference